Hints and tips:
...Our hope is that Inamed’s board will conclude that too,” he said....
...Allergan firmed up 0.7 per cent to $107.31 and Inamed added 1.5 per cent to $87.02....
...Allergan is much larger than Medicis and could easily outbid Medicis in a takeover battle for Inamed, leading many analysts and observers to believe that Medicis is unlikely to raise its offer....
...Medicis, which is involved in a bidding war of its own for Inamed, the breast implant maker, said its board had unanimously rejected the Mentor proposal. Mentor was down 8.5 per cent at $51.35....
...Medicis Pharmaceutical acquired Inamed, a maker of breast implants, for $2.8bn. Inamed shares rose 5 per cent to $69.58, and Medicis shares fell 5.7 per cent to $29.89 for the week....
...Elsewhere, Medicis Pharmaceutical , the skincare products group, said it would acquire Inamed , a maker of breast implants, in a $2.8bn cash and stock deal, sending Inamed shares up 3 per cent to $68.21....
...On Monday, Medicis Pharmaceutical, which specialises in skin--care treatments, lent credence to that view by announcing a $2.8bn acquisition of Inamed, a maker of breast implants....
International Edition